Data from the Project of Ex-Vivo Vein Graft Engineering via Transfection IV ( PREVENT IV ) study , a phase 3 , multicenter , randomized , double-blind , placebo-controlled trial that enrolled 3014 patients at 107 US sites from August 1 , 2002 , through October 22 , 2003 , were used .